Evelyn Calderon
Psychiatric/Mental Health · Orlando, FLNPI 1497241103
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,578 and has fallen 52.7% since, to $1,218 in 2025. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 136 payments — averaging $61.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Neurocrine Biosciences, Inc.$1K
- Alkermes, Inc.$911
- Axsome Therapeutics, Inc.$895
- Otsuka America Pharmaceutical, Inc.$871
- E.r. Squibb & Sons, L.L.C.$493
- plus $3K from 20 others
What the payments were for
- Food & beverage$8,346100%
- Education$270%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $1,163 |
| Neurocrine Biosciences, Inc. | 12 | $1,049 |
| Alkermes, Inc. | 19 | $911 |
| Axsome Therapeutics, Inc. | 11 | $895 |
| Otsuka America Pharmaceutical, Inc. | 11 | $871 |
| E.r. Squibb & Sons, L.L.C. | 11 | $493 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $479 |
| Gilead | 4 | $344 |
| Biogen | 3 | $307 |
| Teva Pharmaceuticals USA, Inc. | 2 | $202 |
| Indivior Inc. | 8 | $166 |
| USWM, LLC | 6 | $151 |
| Shield Therapeutics Inc | 1 | $125 |
| Grifols USA, LLC | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Sanofi | 1 | $122 |
| Johnson & Johnson | 1 | $120 |
| Paratek Pharmaceuticals, Inc. | 1 | $110 |
| Braeburn Inc. | 4 | $109 |
| Amgen | 1 | $101 |
| GSK | 1 | $92 |
| GRT US Holding, Inc. | 1 | $89 |
| Atricure, Inc. | 1 | $79 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $77 |
| Masimo Corporation | 2 | $37 |
| Luye Pharma (USA) Ltd. | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$888
- INGREZZA$851
- Auvelity$720
- ARISTADA$500
- VRAYLAR$486
- CAPLYTA$479
- ABILIFY MAINTENA$471
- COBENFY$355
- Epclusa$239
- ABILIFY ASIMTUFII$232
- Austedo XR$131
- ARISTADA INITIO$125
- ACCRUFER$125
- Prolastin-C Liquid$125
- Fanapt$125
- FABRAZYME$122
- INVEGA SUSTENNA$120
- INVEGA TRINZA$120
- REXULTI$118
- VIVITROL$112
How this compares
$8,373 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Orlando
- Elizabeth GueldeOrlando$48K
- Amber SiegelOrlando$17K
- Orville MurrayOrlando$13K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.